FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980148037> ?p ?o ?g. }

• W2980148037 abstract "Abstract Abstract 1274 Translocations involving the IGH@ locus have recently been characterised as a novel cytogenetic subgroup in BCP-ALL, involving unique partner genes including: CEBP family of transcription factors; cytokine receptors, EPOR and CRLF2; and the inhibitory transcription factor, ID4. As for the mature B-cell malignancies, their expression is always deregulated by juxtaposition of transcriptional enhancers within the locus. We have developed a high throughput FISH screening approach to ascertain the true incidence of IGH@ translocations in BCP-ALL. We screened approximately 80% (2603/3194) of patients entered to the childhood clinical trial (UKALL2003) using an IGH@ break-apart rearrangement probe with automated scanning and capture (CytoVision scanning system, Leica Microsystems). We identified IGH@ translocations in 4% (104/2603) of patients tested. This included an incidence of 4% (96/2286) in BCP-ALL and the novel observation of 2% (8/317) in T-ALL patients. The median age at diagnosis of BCP- and T-ALL IGH@ translocation patients was significantly higher at 12 and 14 years, respectively, compared to the median age of 5 years for the whole trial. The median white cell count (WCC) was low in IGH@ positive BCP-ALL (median 9.05×109/L) and higher in T-ALL (median 72.8×109/L). This study confirmed CRLF2 to be the most frequent IGH@ partner gene, observed in 20% (22/104) of BCP-ALL patients. ID4 and the CEBP family were found in 8% (8/104) and 9% (10/104), respectively. CEBPD was most common (n=6), while CEBPA (n=2), CEBPE (n=1) and CEBPG (n=1) were rare. Single patients were identified with involvement of BCL2, IGF2BP1, IGK@ and the TCRA/D locus. Novel involvement of TAL1 was identified in one T-ALL patient. In 57% of children (59/104: BCP-ALL n=52, T-ALL n=7) the IGH@ translocation partner gene remains unknown. Patients with a known partner gene did not differ from those with an unknown partner gene with respect to gender, age, WCC and National Cancer Institute (NCI) risk. However, patients with a known partner gene were strongly associated with an intermediate cytogenetic risk group while patients with an unknown partner gene were mixed (good risk, 7% v 19%, intermediate risk, 93% v 69% and poor risk, 0% v 12% p=0.01). There was no difference seen for gender, age, WCC, cytogenetic risk and NCI risk when each partner gene was investigated independently, apart from those with CRLF2 involvement who had a higher WCC (<50×109/L 59% v 81% and >50×109/l 41% v 12%, p=0.005) and were solely within the intermediate cytogenetic risk group (100% v 74%, p=0.03). We investigated copy number aberrations of genes commonly altered in BCP-ALL by Multiplex Ligation-dependent Probe Amplification (MLPA) using the Salsa P335-A1 IKZF1 kit (MRC Holland) in 60 IGH@ translocation patients. The genes investigated were IKZF1, CDKN2A/B, PAX5, EBF1, ETV6, BTG1, RB1, as well as the rearrangement, P2RY8-CRLF2. Deletions of none (31%), one (18%), two (17%), three (22%) or four (8%) genes were found. Deletions of CDKN2A, CDKN2B and IKZF1 were the most frequent, in 18%, 21% and 20%, respectively. Whilst the incidence of CDKN2A/B deletions was similar to that seen in childhood BCP-ALL, IKZF1 deletions were more prevalent (20% v 14%) and PAX5 deletions occurred at a lower incidence in IGH@ rearranged patients (13% v 19%). In the two T-ALL patients with DNA available, both showed deletions of CDKN2A with one patient also showing deletion of CDKN2B. In conclusion, IGH@ translocations are present in 4% of childhood ALL with involvement in both B- and T-cell disease. Patients belong to the intermediate cytogenetic risk group with an increased incidence of IKZF1 deletions. This differs from our recent report on adult BCP-ALL, where patients with an IGH@ translocation were associated with a worse outcome, although the increased incidence of IKZF1 deletions remained consistent across all age ranges. In over 50% of IGH@ positive children, the translocation partner remains to be elucidated, indicating the presence of as yet unidentified cryptic rearrangements. Characterisation of these partners may identify additional oncogenes involved in leukemogenesis or provide potential novel therapeutic targets, as recently demonstrated for CRLF2 in BCP-ALL. Disclosures: No relevant conflicts of interest to declare." @default.
• W2980148037 created "2019-10-18" @default.
• W2980148037 creator A5005434648 @default.
• W2980148037 creator A5029209917 @default.
• W2980148037 creator A5031962855 @default.
• W2980148037 creator A5037230262 @default.
• W2980148037 creator A5038422784 @default.
• W2980148037 creator A5047316860 @default.
• W2980148037 creator A5053746950 @default.
• W2980148037 creator A5090798039 @default.
• W2980148037 date "2012-11-16" @default.
• W2980148037 modified "2023-10-06" @default.
• W2980148037 title "Immunoglobulin Heavy Chain Locus (IGH@) Translocations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Incidence and Risk Stratification" @default.
• W2980148037 doi "https://doi.org/10.1182/blood.v120.21.1274.1274" @default.
• W2980148037 hasPublicationYear "2012" @default.
• W2980148037 type Work @default.
• W2980148037 sameAs 2980148037 @default.
• W2980148037 citedByCount "2" @default.
• W2980148037 countsByYear W29801480372013 @default.
• W2980148037 countsByYear W29801480372023 @default.
• W2980148037 crossrefType "journal-article" @default.
• W2980148037 hasAuthorship W2980148037A5005434648 @default.
• W2980148037 hasAuthorship W2980148037A5029209917 @default.
• W2980148037 hasAuthorship W2980148037A5031962855 @default.
• W2980148037 hasAuthorship W2980148037A5037230262 @default.
• W2980148037 hasAuthorship W2980148037A5038422784 @default.
• W2980148037 hasAuthorship W2980148037A5047316860 @default.
• W2980148037 hasAuthorship W2980148037A5053746950 @default.
• W2980148037 hasAuthorship W2980148037A5090798039 @default.
• W2980148037 hasConcept C104317684 @default.
• W2980148037 hasConcept C126322002 @default.
• W2980148037 hasConcept C138626823 @default.
• W2980148037 hasConcept C143998085 @default.
• W2980148037 hasConcept C203014093 @default.
• W2980148037 hasConcept C45091340 @default.
• W2980148037 hasConcept C54355233 @default.
• W2980148037 hasConcept C71924100 @default.
• W2980148037 hasConcept C84597430 @default.
• W2980148037 hasConcept C86339819 @default.
• W2980148037 hasConcept C86803240 @default.
• W2980148037 hasConcept C90924648 @default.
• W2980148037 hasConceptScore W2980148037C104317684 @default.
• W2980148037 hasConceptScore W2980148037C126322002 @default.
• W2980148037 hasConceptScore W2980148037C138626823 @default.
• W2980148037 hasConceptScore W2980148037C143998085 @default.
• W2980148037 hasConceptScore W2980148037C203014093 @default.
• W2980148037 hasConceptScore W2980148037C45091340 @default.
• W2980148037 hasConceptScore W2980148037C54355233 @default.
• W2980148037 hasConceptScore W2980148037C71924100 @default.
• W2980148037 hasConceptScore W2980148037C84597430 @default.
• W2980148037 hasConceptScore W2980148037C86339819 @default.
• W2980148037 hasConceptScore W2980148037C86803240 @default.
• W2980148037 hasConceptScore W2980148037C90924648 @default.
• W2980148037 hasLocation W29801480371 @default.
• W2980148037 hasOpenAccess W2980148037 @default.
• W2980148037 hasPrimaryLocation W29801480371 @default.
• W2980148037 hasRelatedWork W1951609347 @default.
• W2980148037 hasRelatedWork W2080611686 @default.
• W2980148037 hasRelatedWork W2111606093 @default.
• W2980148037 hasRelatedWork W2119806532 @default.
• W2980148037 hasRelatedWork W2222391466 @default.
• W2980148037 hasRelatedWork W2385684414 @default.
• W2980148037 hasRelatedWork W2391292032 @default.
• W2980148037 hasRelatedWork W2432809141 @default.
• W2980148037 hasRelatedWork W2463704141 @default.
• W2980148037 hasRelatedWork W2544866590 @default.
• W2980148037 hasRelatedWork W2553651424 @default.
• W2980148037 hasRelatedWork W2556978513 @default.
• W2980148037 hasRelatedWork W2560987040 @default.
• W2980148037 hasRelatedWork W2589523151 @default.
• W2980148037 hasRelatedWork W2607424741 @default.
• W2980148037 hasRelatedWork W2765885987 @default.
• W2980148037 hasRelatedWork W2787896225 @default.
• W2980148037 hasRelatedWork W2791595674 @default.
• W2980148037 hasRelatedWork W2985525513 @default.
• W2980148037 hasRelatedWork W814637397 @default.
• W2980148037 isParatext "false" @default.
• W2980148037 isRetracted "false" @default.
• W2980148037 magId "2980148037" @default.
• W2980148037 workType "article" @default.